NIH PAR · NIDCR · UG3, UH3
PAR-27-015: Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit UG3/UH3 phased, cooperative agreement research applications to evaluate, implement, and/or test population-based interventions to policies, programs, and/or practices for promoting integration of services, systems, and/or values by leveraging cross-sector partnerships in communities. Such interventions must address social and chronic disease common risk factors and/or barriers driving oral disease burden in communities. Projects funded through this funding opportunity and a separately funded Community Engagement Evaluation and Data Coordination hub (CEED) will form a Community-Based Participatory Research (CBPR)…
- NOFO number
- PAR-27-015
- Type
- PAR
- Activity code
- UG3UH3
- Primary institute
- NIDCR · National Institute of Dental and Craniofacial Research
- Clinical trials
- Optional
- Posted
- Apr 27, 2026
- Opens
- Sep 16, 2026
- Expires
- Nov 17, 2028
PAR-27-015 due dates
3 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| October 16, 2026 | November 16, 2026 | Not Applicable | March 2027 | May 2027 | July 2027 |
| October 16, 2027 | November 16, 2027 | Not Applicable | March 2028 | May 2028 | July 2028 |
| October 16, 2028 | November 16, 2028 | Not Applicable | March 2029 | May 2029 | July 2029 |
Funded projects
NIH RePORTER lists no awards under PAR-27-015 in FY2022–FY2026, and it is a new NOFO rather than a reissue. Awards usually appear a few months after the first review cycle.
Participating institutes
6 NIH institutes and offices take applications under PAR-27-015. Contact the program officer at the institute that fits your research before applying.
- NIDCR · National Institute of Dental and Craniofacial Research
- OAR
- NIMHD · National Institute on Minority Health and Health Disparities
- ODP
- OBSSR
- ORWH
Related notices
NIH lists no related notices for PAR-27-015 yet.
Award terms
- Application types allowed
- New Resubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are limited to 300,000 per year in direct costs for UG3 Phase 1), and 650,000 per year in direct costs for UH3 Phase 2).
- Project period
- The maximum project period is 7 years. This includes 2 years for the UG3 Phase 1) and 5 years for the UH3 Phase 2). NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Companion NOFOs: RFA-DE-27-001.
Other open NOFOs for UG3, UH3
- PAR-25-062Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)NIDCR · next due Nov 9, 2026
- PAR-25-188NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)NIDCR · next due Feb 8, 2027
- PAR-25-057NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)NIDCR · next due Feb 8, 2027
- PAR-25-296Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)NCATS · next due Oct 19, 2026
- PAR-24-293Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)NINDS · next due Jan 15, 2027
- PAR-25-383Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)NINDS · next due Jan 28, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.